{"ANSWER_QUALITY":{"q1":{"text":"What is an Atherosclerotic Cardiovascular Disease?","index":0,"answers":[{"text":"Atherosclerotic cardiovascular disease (ASCVD) is a condition in which plaque builds up inside the arteries, leading to a narrowing or blockage of blood flow. This can cause a heart attack, stroke, or other serious cardiovascular problems.","system":"experiment_1e","overall_rating":1,"confidence_rating":1,"inaccurate_text":"","external_text":"","Does any part of the answer say 'I don’t know' or that there’s 'insufficient context' to provide an answer?":"","The answer is relevant to the question (regardless of whether the details are correct or not).":"","The answer contains inaccurate information (e.g., information that is made up or not true).":"","The answer contains information not found in the document (e.g., information that does not exist in this document).":"","The answer contains irrelevant information (e.g., information that is irrelevant).":"","This answer is useful and helpful to address this question.":"","The answer contains enough information for the question.":"","The answer completely answers the whole question (e.g., it covers every aspect of the question).":"","The answer is missing specific details from the document.":"","The answer is wordy (e.g., unnecessarily long or contains unnecessary words).":"","The answer is easy to read and comprehend.":"","The answer has been written by an expert.":"","I can trust this answer":""}]},"q2":{"text":"When are high intensity statins recommended?","index":0,"answers":[{"text":"High-intensity statins are recommended for all patients with familial hypercholesterolemia (FH), and nonstatin lipid-lowering therapies (LLTs) are indicated when there is an inadequate response to statins. They are also recommended for patients with atherosclerotic cardiovascular disease (ASCVD).","system":"experiment_1e","overall_rating":1,"confidence_rating":1,"inaccurate_text":"","external_text":"","Does any part of the answer say 'I don’t know' or that there’s 'insufficient context' to provide an answer?":"","The answer is relevant to the question (regardless of whether the details are correct or not).":"","The answer contains inaccurate information (e.g., information that is made up or not true).":"","The answer contains information not found in the document (e.g., information that does not exist in this document).":"","The answer contains irrelevant information (e.g., information that is irrelevant).":"","This answer is useful and helpful to address this question.":"","The answer contains enough information for the question.":"","The answer completely answers the whole question (e.g., it covers every aspect of the question).":"","The answer is missing specific details from the document.":"","The answer is wordy (e.g., unnecessarily long or contains unnecessary words).":"","The answer is easy to read and comprehend.":"","The answer has been written by an expert.":"","I can trust this answer":""}]},"q3":{"text":"What is the pre-PCSK9 inhibitor (PCSK9i) era?","index":0,"answers":[{"text":"The pre-PCSK9 inhibitor (PCSK9i) era refers to the time period before PCSK9 inhibitors were approved for the treatment of heterozygous and homozygous familial hypercholesterolemia (FH) in 2015.","system":"experiment_1e","overall_rating":1,"confidence_rating":1,"inaccurate_text":"","external_text":"","Does any part of the answer say 'I don’t know' or that there’s 'insufficient context' to provide an answer?":"","The answer is relevant to the question (regardless of whether the details are correct or not).":"","The answer contains inaccurate information (e.g., information that is made up or not true).":"","The answer contains information not found in the document (e.g., information that does not exist in this document).":"","The answer contains irrelevant information (e.g., information that is irrelevant).":"","This answer is useful and helpful to address this question.":"","The answer contains enough information for the question.":"","The answer completely answers the whole question (e.g., it covers every aspect of the question).":"","The answer is missing specific details from the document.":"","The answer is wordy (e.g., unnecessarily long or contains unnecessary words).":"","The answer is easy to read and comprehend.":"","The answer has been written by an expert.":"","I can trust this answer":""}]},"q4":{"text":"What are lipid-lowering therapies (LLTs)?","index":0,"answers":[{"text":"Lipid-lowering therapies (LLTs) are medications used to lower levels of cholesterol and other lipids in the blood. They include high-intensity statins, moderate-intensity statins, and nonstatin therapies such as ezetimibe and PCSK9 inhibitors. These therapies are used to reduce the risk of atherosclerotic cardiovascular disease (ASCVD) in high-risk patients, including those with familial hypercholesterolemia (FH) or ASCVD.","system":"experiment_1e","overall_rating":1,"confidence_rating":1,"inaccurate_text":"","external_text":"","Does any part of the answer say 'I don’t know' or that there’s 'insufficient context' to provide an answer?":"","The answer is relevant to the question (regardless of whether the details are correct or not).":"","The answer contains inaccurate information (e.g., information that is made up or not true).":"","The answer contains information not found in the document (e.g., information that does not exist in this document).":"","The answer contains irrelevant information (e.g., information that is irrelevant).":"","This answer is useful and helpful to address this question.":"","The answer contains enough information for the question.":"","The answer completely answers the whole question (e.g., it covers every aspect of the question).":"","The answer is missing specific details from the document.":"","The answer is wordy (e.g., unnecessarily long or contains unnecessary words).":"","The answer is easy to read and comprehend.":"","The answer has been written by an expert.":"","I can trust this answer":""}]},"q5":{"text":"What do you know about the FOCUS study?","index":0,"answers":[{"text":"The FOCUS study (FH Optimal Care of the US) was designed by The FH Foundation to assess current treatment patterns of FH patients, and allowed the assessment of rejection rates of PCSK9 inhibitors in those with FH or atherosclerotic cardiovascular disease (ASCVD). The study found that high-risk patients, including those with presumptive FH or ASCVD, have high rates of rejection for PCSK9i prescriptions even when there is sufficient evidence that they have inadequately controlled LDL-C despite concurrent appropriate statin-based LLT. The FH Foundation contracted with Atomo, Inc., to perform this analysis.","system":"experiment_1e","overall_rating":1,"confidence_rating":1,"inaccurate_text":"","external_text":"","Does any part of the answer say 'I don’t know' or that there’s 'insufficient context' to provide an answer?":"","The answer is relevant to the question (regardless of whether the details are correct or not).":"","The answer contains inaccurate information (e.g., information that is made up or not true).":"","The answer contains information not found in the document (e.g., information that does not exist in this document).":"","The answer contains irrelevant information (e.g., information that is irrelevant).":"","This answer is useful and helpful to address this question.":"","The answer contains enough information for the question.":"","The answer completely answers the whole question (e.g., it covers every aspect of the question).":"","The answer is missing specific details from the document.":"","The answer is wordy (e.g., unnecessarily long or contains unnecessary words).":"","The answer is easy to read and comprehend.":"","The answer has been written by an expert.":"","I can trust this answer":""}]},"q6":{"text":"What does the FOCUS data indicate about high risk patients?","index":0,"answers":[{"text":"The FOCUS data indicate that high-risk patients, including those with presumptive FH or ASCVD, have high rates of rejection for PCSK9i prescriptions even when there is sufficient evidence that they have inadequately controlled LDL-C despite concurrent appropriate statin-based LLT.","system":"experiment_1e","overall_rating":1,"confidence_rating":1,"inaccurate_text":"","external_text":"","Does any part of the answer say 'I don’t know' or that there’s 'insufficient context' to provide an answer?":"","The answer is relevant to the question (regardless of whether the details are correct or not).":"","The answer contains inaccurate information (e.g., information that is made up or not true).":"","The answer contains information not found in the document (e.g., information that does not exist in this document).":"","The answer contains irrelevant information (e.g., information that is irrelevant).":"","This answer is useful and helpful to address this question.":"","The answer contains enough information for the question.":"","The answer completely answers the whole question (e.g., it covers every aspect of the question).":"","The answer is missing specific details from the document.":"","The answer is wordy (e.g., unnecessarily long or contains unnecessary words).":"","The answer is easy to read and comprehend.":"","The answer has been written by an expert.":"","I can trust this answer":""}]},"q7":{"text":"What is the FOURIER trial?","index":0,"answers":[{"text":"The article mentions the FOURIER trial, but it does not provide a detailed explanation of what it is.","system":"experiment_1e","overall_rating":1,"confidence_rating":1,"inaccurate_text":"","external_text":"","Does any part of the answer say 'I don’t know' or that there’s 'insufficient context' to provide an answer?":"","The answer is relevant to the question (regardless of whether the details are correct or not).":"","The answer contains inaccurate information (e.g., information that is made up or not true).":"","The answer contains information not found in the document (e.g., information that does not exist in this document).":"","The answer contains irrelevant information (e.g., information that is irrelevant).":"","This answer is useful and helpful to address this question.":"","The answer contains enough information for the question.":"","The answer completely answers the whole question (e.g., it covers every aspect of the question).":"","The answer is missing specific details from the document.":"","The answer is wordy (e.g., unnecessarily long or contains unnecessary words).":"","The answer is easy to read and comprehend.":"","The answer has been written by an expert.":"","I can trust this answer":""}]},"q8":{"text":"Compare the prescribed ezetimibe of FH and ASCVD patients in accordance with claims adjudication data.","index":0,"answers":[{"text":"According to the claims adjudication data, 5442 presumed FH patients were prescribed ezetimibe, of whom 2573 had an LDL-C >190 mg/dL despite evidence of high-intensity or moderate-intensity statins. In comparison, 1622 patients with established ASCVD who had an LDL-C value >100 mg/dL despite evidence of being treated with appropriate LLT were prescribed ezetimibe. The rejection rate for ezetimibe prescriptions in a similar ASCVD population was 8.2%.","system":"experiment_1e","overall_rating":1,"confidence_rating":1,"inaccurate_text":"","external_text":"","Does any part of the answer say 'I don’t know' or that there’s 'insufficient context' to provide an answer?":"","The answer is relevant to the question (regardless of whether the details are correct or not).":"","The answer contains inaccurate information (e.g., information that is made up or not true).":"","The answer contains information not found in the document (e.g., information that does not exist in this document).":"","The answer contains irrelevant information (e.g., information that is irrelevant).":"","This answer is useful and helpful to address this question.":"","The answer contains enough information for the question.":"","The answer completely answers the whole question (e.g., it covers every aspect of the question).":"","The answer is missing specific details from the document.":"","The answer is wordy (e.g., unnecessarily long or contains unnecessary words).":"","The answer is easy to read and comprehend.":"","The answer has been written by an expert.":"","I can trust this answer":""}]}},"GENERATED_QUESTIONS":{"q1":{"text":"What is an Atherosclerotic Cardiovascular Disease?","highlights":[]},"q2":{"text":"When are high intensity statins recommended?","highlights":[]},"q3":{"text":"What is the pre-PCSK9 inhibitor (PCSK9i) era?","highlights":[]},"q4":{"text":"What are lipid-lowering therapies (LLTs)?","highlights":[]},"q5":{"text":"What do you know about the FOCUS study?","highlights":[]},"q6":{"text":"What does the FOCUS data indicate about high risk patients?","highlights":[]},"q7":{"text":"What is the FOURIER trial?","highlights":[]},"q8":{"text":"Compare the prescribed ezetimibe of FH and ASCVD patients in accordance with claims adjudication data.","highlights":[]}}}